KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Payables (2016 - 2025)

Elevance Health (ELV) has disclosed Payables for 17 consecutive years, with $6.3 billion as the latest value for Q3 2025.

  • On a quarterly basis, Payables fell 5.29% to $6.3 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $6.3 billion, a 5.29% decrease, with the full-year FY2024 number at $7.3 billion, up 2.2% from a year prior.
  • Payables was $6.3 billion for Q3 2025 at Elevance Health, down from $7.6 billion in the prior quarter.
  • In the past five years, Payables ranged from a high of $7.6 billion in Q2 2025 to a low of $4.9 billion in Q1 2023.
  • A 5-year average of $6.1 billion and a median of $5.9 billion in 2021 define the central range for Payables.
  • Peak YoY movement for Payables: dropped 16.73% in 2022, then soared 48.43% in 2024.
  • Elevance Health's Payables stood at $5.2 billion in 2021, then increased by 11.95% to $5.9 billion in 2022, then grew by 21.51% to $7.1 billion in 2023, then rose by 2.2% to $7.3 billion in 2024, then fell by 14.08% to $6.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Payables are $6.3 billion (Q3 2025), $7.6 billion (Q2 2025), and $7.4 billion (Q1 2025).